[go: up one dir, main page]

AU2002213784A1 - A method of local anesthesia and analgesia - Google Patents

A method of local anesthesia and analgesia

Info

Publication number
AU2002213784A1
AU2002213784A1 AU2002213784A AU1378402A AU2002213784A1 AU 2002213784 A1 AU2002213784 A1 AU 2002213784A1 AU 2002213784 A AU2002213784 A AU 2002213784A AU 1378402 A AU1378402 A AU 1378402A AU 2002213784 A1 AU2002213784 A1 AU 2002213784A1
Authority
AU
Australia
Prior art keywords
analgesia
local anesthesia
anesthesia
local
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002213784A
Inventor
Baoshan Ku
Shiquan Qi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wex Medical Instrumentation Co Ltd
Original Assignee
WEX MEDICAL INSTRUMENTATION CO
Wex Medical Instrumentation Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WEX MEDICAL INSTRUMENTATION CO, Wex Medical Instrumentation Co Ltd filed Critical WEX MEDICAL INSTRUMENTATION CO
Publication of AU2002213784A1 publication Critical patent/AU2002213784A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/529—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002213784A 2000-09-18 2001-09-11 A method of local anesthesia and analgesia Abandoned AU2002213784A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNB00124518XA CN1203857C (en) 2000-09-18 2000-09-18 A New Approach to Local Anesthesia and Analgesia
CN00124518 2000-09-18
PCT/CN2001/001390 WO2002022128A1 (en) 2000-09-18 2001-09-11 A method of local anesthesia and analgesia

Publications (1)

Publication Number Publication Date
AU2002213784A1 true AU2002213784A1 (en) 2002-03-26

Family

ID=4590473

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002213784A Abandoned AU2002213784A1 (en) 2000-09-18 2001-09-11 A method of local anesthesia and analgesia

Country Status (6)

Country Link
US (1) US6599906B1 (en)
CN (1) CN1203857C (en)
AU (1) AU2002213784A1 (en)
DE (1) DE10197266T5 (en)
GB (1) GB0406274D0 (en)
WO (1) WO2002022128A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1236773C (en) 2000-11-22 2006-01-18 南宁枫叶药业有限公司 Preparation for analgesia and anesthesia or curing drug dependence
CN1269482C (en) * 2001-05-18 2006-08-16 威克斯医药有限公司 Use of sodium ion channel blocker and opioid analgesic in the preparation of medicines for synergistic analgesia in mammals
EP1443932B1 (en) * 2001-11-15 2012-12-26 Micro Algae Corporation Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission
CN100360133C (en) * 2002-05-23 2008-01-09 潘心富 Tetrodotoxin respiratory tract administration prepn. used for giving-up drug and easing pain
US7868028B2 (en) * 2002-06-17 2011-01-11 Fred Drasner Guanidine compounds as anesthetics and for treatment of nervous system disorders
US6963083B2 (en) * 2003-06-30 2005-11-08 Lg.Philips Lcd Co., Ltd. Liquid crystal display device having polycrystalline TFT and fabricating method thereof
CN1568999A (en) * 2003-07-14 2005-01-26 南宁枫叶药业有限公司 Stable freeze dried formulation of spheroidine for medical use
JP2005154368A (en) * 2003-11-27 2005-06-16 Teikoku Seiyaku Co Ltd Analgesic agent for neuropathic pain containing disopyramide
BRPI0510761A (en) * 2004-05-07 2007-11-20 Phytotox Ltd methods of treating a patient afflicted with at least one condition and reducing or eliminating wrinkles
EP1796676B1 (en) * 2004-05-07 2016-03-09 Phytotox Limited Transdermal administration of phycotoxins
EP1799220A1 (en) * 2004-09-22 2007-06-27 Laboratorios del Dr. Esteve S.A. Tetrodotoxin and its derivatives for the treatment of peripheral-nervously derived neuropathic pain
WO2007025212A2 (en) * 2005-08-25 2007-03-01 Wex Pharmaceuticals, Inc. Use of sodium channel blockers for the treatment of visceral pain or pain caused by cancer treatment
US20100048592A1 (en) * 2005-08-25 2010-02-25 Wex Pharmaceuticals Inc. Use of sodium channel blockers for the management of musculoskeletal pain
US8263047B2 (en) * 2005-09-29 2012-09-11 Wickenhauser Alan J Topical anesthetic for dental procedures
US8623334B1 (en) 2005-09-29 2014-01-07 Alan J. Wickenhauser Topical anesthetic
GB0603008D0 (en) * 2006-02-14 2006-03-29 Portela & Ca Sa Method
ES2691411T3 (en) 2006-03-27 2018-11-27 Wex Medical Limited Use of sodium channel blockers for the treatment of neuropathic pain that develops as a result of chemotherapy
DE102008037682A1 (en) 2008-08-14 2010-04-08 Strackharn, Klaus, Dr.med. Use of equipotent doses of local anesthetics or derivatives thereof for the treatment of chronic pain
US20120310140A1 (en) 2010-12-01 2012-12-06 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
CA2902572A1 (en) 2013-03-14 2014-10-02 Regeneron Pharmaceuticals, Inc. Human antibodies to nav1.7
US8986694B1 (en) 2014-07-15 2015-03-24 Kymab Limited Targeting human nav1.7 variants for treatment of pain
US8992927B1 (en) 2014-07-15 2015-03-31 Kymab Limited Targeting human NAV1.7 variants for treatment of pain
GB201403775D0 (en) 2014-03-04 2014-04-16 Kymab Ltd Antibodies, uses & methods
WO2015195708A1 (en) * 2014-06-16 2015-12-23 Loewi LLC Methods of anesthetizing nerve tissue in the trigeminal nerve pathway and medical uses thereof
JP7461741B2 (en) 2016-06-20 2024-04-04 カイマブ・リミテッド Anti-PD-L1 and IL-2 Cytokines
EP3534947A1 (en) 2016-11-03 2019-09-11 Kymab Limited Antibodies, combinations comprising antibodies, biomarkers, uses & methods
CN117202912A (en) 2021-04-23 2023-12-08 威克斯药业有限公司 Tetrodotoxin liquid preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022899A (en) 1973-06-12 1977-05-10 Astra Pharmaceutical Products, Inc. Synergistic local anesthetic compositions
US4029793A (en) 1973-06-12 1977-06-14 Astra Pharmaceutical Products, Inc. Synergistic local anesthetic compositions
EP0750909B1 (en) 1994-03-17 2002-12-11 Nanning Maple Leaf Pharmaceutical Co., Ltd. The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
CN1072486C (en) * 1996-09-24 2001-10-10 王维国 Medicament for giving up narcotic drugs and stopping pain and its prepn.
US6030974A (en) 1997-04-02 2000-02-29 The Regents Of The University Of California Method of anesthesia
US6326020B1 (en) * 1997-05-16 2001-12-04 Children's Medical Center Corporation Local anesthetic formulations

Also Published As

Publication number Publication date
GB0406274D0 (en) 2004-04-21
DE10197266T5 (en) 2005-05-12
CN1203857C (en) 2005-06-01
CN1343491A (en) 2002-04-10
WO2002022128A1 (en) 2002-03-21
US6599906B1 (en) 2003-07-29

Similar Documents

Publication Publication Date Title
AU2002213784A1 (en) A method of local anesthesia and analgesia
AU2002258995A1 (en) Method and device for neurocryo analgesia and anesthesia
AU2001268546A1 (en) Video system and method of operating a video system
AU2001253833A1 (en) Methods and arrangements for providing a novel television and multimedia viewingparadigm
AU5862601A (en) Searching apparatus and a method of searching
AU2001283546A1 (en) Inhalation device and method
AU2002212592A1 (en) A method of and a system for distributing electronic content
AU2001289171A1 (en) Apparatus and methods of forming a curved structure
AU2001239089A1 (en) Method and device for producing drops of equal size
AU2001290342A1 (en) System and method for comprising manual function for managing a form
AU2001294646A1 (en) Electronic transformer/inductor devices and methods for making same
AU2001284858A1 (en) Improved suturing apparatus and method
AU2001247601A1 (en) Platform and method for remote attestation of a platform
AU2002227414A1 (en) Infusion devices and method
AU2002217868A1 (en) A joint structure and method for making a joint structure
AU2001269308A1 (en) Tape movement constraint and method of constraining movement of a tape
AU2001292486A1 (en) A strap connection and a method of connecting a strap
AU2001251320A1 (en) Multiple index tape feeder and method
AU2002243386A1 (en) Rf2a and rf2b transcription factors
AU2001293091A1 (en) Piezoelectric transformer and operating method
AU2000271273A1 (en) Manifold and method of making same
AU2001249747A1 (en) A meta application system and method
AU3066401A (en) D/a conversion method and apparatus
AU2001290232A1 (en) Report managing device and method
AU2002214013A1 (en) A method of making a gasket on a pcb and a pcb